VeeR VR News In China

[Chinese] Veer VR joined The batch of partner signing ceremony for China Telecom's 5G+ big video application was held in Beijing.

2019年8月19日,中国电信5G+大视频应用首批合作伙伴签约仪式在京举行

VeeR与中国电信旗下号百控股签署合作意向书,将作为5G VR内容平台方,长期提供优质的VR内容。

签约仪式当天,有来自平台、终端以及VR/AR、游戏、视频内容、制作等行业共40余家合作伙伴参加仪式。VeeR作为中国电信积极引入的重要合作方之一,未来或将与号百控股继续深度合作,共同探讨VR内容创作新模式。

今年6月6日,5G商用牌照的发放,标志着中国进入5G商用时代。为更好地促进5G商用,中国电信积极切入5G产业风口,全面加速5G布局。

初期,中国电信的5G网络将覆盖北京、上海、广州、深圳、成都、杭州、南京、苏州、武汉、重庆等全国47个城市。同时,中国电信基于自身的云网资源禀赋的综合优势,积极部署边缘计算、网络切片等核心能力,大力推进5G+云改,为生态赋能,有力支撑了5G应用的创新实践。

中国电信着力面向个人和家庭客户推出5G超高清视频/直播、5G云VR等应用。其中,5G超高清视频以超高清点播、VR直播和一键投屏为亮点;5G云VR则为用户带来高清晰、低时延、3D动态的沉浸式体验。

秉持开放合作的态度,中国电信联合了产业链合作伙伴为5G+大视频应用提供多项支持,包括超高清视频、VR视频等内容合作,媒体资源运营平台构建,5G手机与VR头盔等终端设备供应,共同为用户提供差异化的极致娱乐体验。

VeeR作为环球领先的VR内容平台,聚集了海内外180多个国家和地区的优质VR内容,并在5G到来之际,率先探索出“VR+文旅地标”的新型商业模式,成功推动了5G商用落地

此次与中国电信合作后,双方除了会继续探索5G应用的新业务、新场景、新模式,VeeR还将逐步开放VR内容平台给更多的合作伙伴,让更多用户看到优质的VR内容。

UC BERKELEY SPIN OFF BIOTECH STARTUP mFluiDx JOINED OUR PORTFOLIO

March 2019,

mFluiDx is a UC Berkeley startup developing Gates Foundation funded low-cost microfluidic diagnostic technologies capable of on-site multi-target isothermal DNA detection of infectious diseases with simple operation and ~100X lower cost than PCR setups. mFluiDx aims to create assays that can be deployed in decentralized settings, are as simple and cheap as paper tests, yet have DNA level sensitivity for onsite diagnosis.

mFluiDx is aiming to develop the world’s lowest cost, automated point-of-care DNA diagnostic assay for small clinics. In small clinics, such as primary care out-patient clinics, disease diagnosis is typically done by observing symptoms or using paper-strip antibody tests. However, these methods have poor sensitivity compared to DNA diagnostics. Highly sensitive molecular DNA tests (PCR) are not often used because of cost and the need to send tests off-site resulting in a slow turnaround time (several days).